Trials / Completed
CompletedNCT00363857
A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome
A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering From Restless Legs Syndrome (RLS)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 360 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
A 14-Week clinical research study to compare the effectiveness and safety of ropinirole and placebo (an inactive sugar pill) in the treatment of patients with Restless Legs Syndrome (RLS) in the United States.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropinirole |
Timeline
- Start date
- 2003-08-01
- Primary completion
- 2004-05-01
- Completion
- 2004-05-01
- First posted
- 2006-08-15
- Last updated
- 2016-10-17
Locations
49 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00363857. Inclusion in this directory is not an endorsement.